An Update on Treatment Options for Primary Sclerosing Cholangitis

An Update on Treatment Options for Primary Sclerosing Cholangitis Publisher

Iravani S^{1, 2} ; Dooghaiemoghadam A³ ; Razavikhorasani N³ ; Moazzami B³ ; Beirami AD⁴ ; Mansourghanaei A⁴ ; Majidzadeha K¹ ; Mehrvar A¹ ; Khoshdel A¹ ; Toosi MN³ ; Sadeghi A⁴

Show Affiliations

1. Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran
2. Gastroenterology and Hepatobiliary Research Center, AJA University of Medical Sciences, Tehran, Iran
3. Liver Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Department of Liver Transplantation, Imam Khomeini Hospital, Keshavarz Blvd, Tehran, Iran

Source: Gastroenterology and Hepatology from Bed to Bench Published:2020

Abstract

Primary sclerosing cholangitis is a chronic cholestatic liver disease defined by strictures of the biliary tree which could ultimately lead to liver cirrhosis and cholangiocarcinoma. Although the exact underlying etiology of this disorder is not fully understood, the pathology is believed to be caused by immune mediated mechanisms. Growing body of evidence suggests several treatment modalities mainly focusing on the inflammation aspect of this disorder. However, there is still no consensus regarding the best treatment option for these patients. Thus, the present study aimed to review the current treatment options for patients with primary sclerosing cholangitis. © 2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases.

Related Docs

1. Psc Associated Inflammatory Bowel Disease: A Distinct Entity, Expert Review of Gastroenterology and Hepatology (2022)

2. The Clinical Significance of Biliary Findings in Magnetic Resonance Enterography of Patients With Inflammatory Bowel Disease, Polish Journal of Radiology (2022)

3. A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: A Pilot Study, Journal of Gastrointestinal and Liver Diseases (2016)

Experts (# of related papers)

View all Related Experts

Hossein Khalili (1)

Majid Sorouri (1)

Style	Citing Format
MLA	Iravani S, et al.. "An Update on Treatment Options for Primary Sclerosing Cholangitis." Gastroenterology and Hepatology from Bed to Bench, vol. 13, no. 2, 2020, pp. 115-124.
APA	Iravani S, Dooghaiemoghadam A, Razavikhorasani N, Moazzami B, Beirami AD, Mansourghanaei A, Majidzadeha K, Mehrvar A, Khoshdel A, Toosi MN, Sadeghi A (2020). An Update on Treatment Options for Primary Sclerosing Cholangitis. Gastroenterology and Hepatology from Bed to Bench, 13(2), 115-124.
Chicago	Iravani S, Dooghaiemoghadam A, Razavikhorasani N, Moazzami B, Beirami AD, Mansourghanaei A, Majidzadeha K, et al.. "An Update on Treatment Options for Primary Sclerosing Cholangitis." Gastroenterology and Hepatology from Bed to Bench 13, no. 2 (2020): 115-124.
Harvard	Iravani S et al. (2020) 'An Update on Treatment Options for Primary Sclerosing Cholangitis', Gastroenterology and Hepatology from Bed to Bench, 13(2), pp. 115-124.
Vancouver	Iravani S, Dooghaiemoghadam A, Razavikhorasani N, Moazzami B, Beirami AD, Mansourghanaei A, et al.. An Update on Treatment Options for Primary Sclerosing Cholangitis. Gastroenterology and Hepatology from Bed to Bench. 2020;13(2):115-124.
BibTex	@article{ author = {Iravani S and Dooghaiemoghadam A and Razavikhorasani N and Moazzami B and Beirami AD and Mansourghanaei A and Majidzadeha K and Mehrvar A and Khoshdel A and Toosi MN and Sadeghi A}, title = {An Update on Treatment Options for Primary Sclerosing Cholangitis}, journal = {Gastroenterology and Hepatology from Bed to Bench}, volume = {13}, number = {2}, pages = {115-124}, year = {2020} }
RIS	TY - JOUR AU - Iravani S AU - Dooghaiemoghadam A AU - Razavikhorasani N AU - Moazzami B AU - Beirami AD AU - Mansourghanaei A AU - Majidzadeha K AU - Mehrvar A AU - Khoshdel A AU - Toosi MN AU - Sadeghi A TI - An Update on Treatment Options for Primary Sclerosing Cholangitis JO - Gastroenterology and Hepatology from Bed to Bench VL - 13 IS - 2 SP - 115 EP - 124 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract